Ledger.Open graph →
SEC Form D · filed December 3, 2010

Helix Therapeutics, Inc

Offering
$3.5M
Sold
$2.5M
Exemption
—
Industry
Biotechnology
Location
NEW HAVEN, CT
Type
—

People & firms on this filing (9)

Joseph Catino · New Haven, CTExec · DirectorPeter Glazer · New Haven, CTDirector · PromoterJoseph Catino · Guilford, CTExec · DirectorTimothy Shannon · New York, NYDirectorRussell Tweeddale · New Haven, CTDirectorPeter Glazer · New Haven, CTDirector · PromoterKevin Rakin · New Haven, CTDirector · PromoterGerald Vovis · New Haven, CTPromoterRanjit Bindra · New Haven, CTPromoter

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗